Meta-analysis of 8 single-arm pre-post studies in Parkinson's disease with overactive bladder: mirabegron or onabotulinumtoxinA were associated with fewer daily voids (MD −4.48), nocturia and incontinence; urgency change was non-significant. Evidence certainty low to moderate.
Meta-analysisn = 8 studies
Arshad et al. Mirabegron and Intradetrusor Onabotulinumtoxina for Overactive Bladder in Parkinson's Disease: A Systematic Review and Meta-Analysis